Where COVID-19 is hitting state economies the hardest

Louisiana is the most exposed state economy when it comes to the new coronavirus, COVID-19.

The COVID-19 pandemic has caused significant economic disruptions, with the stock market dropping about 20% and unemployment soaring.

That’s according to WalletHub, which ranked states across 10 key metrics, looking at the share of employment by small businesses, the share of GDP from highly affected industries in a state, and unemployment claims.

While Louisiana was the most exposed state overall, Rhode Island actually saw the highest increase in the number of initial unemployment insurance claims, at 4,574.93% in the 12th week of 2020 compared to the same time period in 2019. Utah, which had the lowest increase in unemployment insurance claims, saw a 50.52% increase.

Here are the top 10 states with most exposed economies:

  • Louisiana
  • Rhode Island
  • Nevada
  • Maine
  • New Hampshire
  • Pennsylvania
  • Montana
  • New Jersey
  • Massachusetts
  • Illinois

Mississippi, Louisiana, Alabama, West Virginia and Arkansas had the lowest share of workers working from home. Several states and businesses have shifted to working from home to keep people from congregating at office buildings and spreading the virus.

Here are the states with the least exposed economies

  • Arkansas
  • Nebraska
  • Alabama
  • South Dakota
  • Utah
  • Oregon
  • Alaska
  • California
  • Georgia

See the full report here.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.